FolioLanternBeta
GRDNGuardian Pharmacy Services, Inc. · Insider ownership research

Guardian Pharmacy Services, Inc. insiders sold $419M in the past 12 months. How much of their stake is that?

Insiders sold $419M in the past 12 months.0% was sold under disclosed trading plans, 100% with no plan disclosed. The largest seller, Thomas Salentine Jr. (Director), sold $212M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why

Updated Oct 13, 2026 from SEC filings · covers Oct 14, 2025 to Oct 13, 2026
1
buyer among officers and directors (1 trade), past 12 months
0%
of sales were under disclosed trading plans, past 12 months
6 of 16
officers and directors sold shares, past 12 months
Latest filing: Filed Sep 28 for a conversion on Sep 27. Thomas Salentine Jr. converted 12.20M shares between classes. Filing
SEC ownership filings: 52 filed in the 12 months to Oct 13, 2026; 101 on record since Sep 25, 2024 · See the evidence

What stands out

Six insiders sold $419M with no disclosed plan: Thomas Salentine Jr. ($212M), William Bindley ($106M) and John Ackerman ($65.5M), plus 3 more. The filings don't state a reason.Thomas Salentine Jr.: largest such sale, Mar 20, 2026 · William Bindley: largest such sale, Mar 20, 2026 · John Ackerman: largest such sale, Mar 20, 2026
Steven Cosler bought 3.4K shares for $100K, first on Dec 3, 2025.Purchase, Dec 3, 2025

A share of stake is shown for 0 of the 6 officers and directors who sold. 16 are left out

i
Left out: Thomas Salentine Jr., William Bindley, John Ackerman, Fred Burke, David Morris, Kendall Forbes, Jeffrey Tuch, David Martin, William Mudd, Richard Eakins, Douglas Towns, Robert Weir, Chris Crisafulli, Steven Cosler, Randall Lewis and Mary Patchett (share of stake is being verified).
Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Thomas Salentine Jr.
Director
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$212MNo plan disclosed
William Bindley
Director
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$106MNo plan disclosed
John Ackerman
Director
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$65.5MNo plan disclosed
Fred Burke
President and Chief Executive Officer, Director
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$19.9MNo plan disclosed
Kendall Forbes
Officer
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$10.3MNo plan disclosed
All 6 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $419M no plan disclosed$419MMarAprMayJunJulAugSepOct

Recent activity

Past 30 days, Sep 14, 2026 to Oct 13, 2026

Share-class conversions: 1 conversion, 24,855,390 shares Class B → Class A. A conversion is not a sale; the combined stake does not change.

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Common questions

Is the Guardian Pharmacy Services, Inc. CEO selling stock?

Yes. Fred Burke sold 671K shares ($19.9M) in the past 12 months, none of it under a trading plan disclosed in the filings.

Why are Guardian Pharmacy Services, Inc. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 100% had no disclosed plan. A trading plan schedules sales in advance.

Are any Guardian Pharmacy Services, Inc. insiders buying?

Yes. 1 officer or director reported 1 purchase in the past 12 months (Form 4 code P; rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust are not counted).

The evidence

Who sold6 officers and directors: amount, % of holdings, trading plan
Who soldAmount% of holdingsTrading plan
Thomas Salentine Jr.
Director
$212M
7.14M shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
William Bindley
Director
$106M
3.57M shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
John Ackerman
Director
$65.5M
2.21M shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
Fred Burke
President and Chief Executive Officer, Director
$19.9M
671K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
Kendall Forbes
Officer
$10.3M
347K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
David Morris
Executive Vice President, Chief Operating Officer, Director
$5.6M
188K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
The full ownership picture0 of 16 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

InsiderHeld Oct 13, 2025SoldHeld Oct 13, 2026Still held
Thomas Salentine Jr.
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Thomas Salentine Jr. are complete.
Director
n/a−7.14Mn/an/a
Vesting, gifts, unvested awards and holding lines for Thomas Salentine Jr.

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Thomas Salentine Jr. are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
William Bindley
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for William Bindley are complete.
Director
n/a−3.57Mn/an/a
Vesting, gifts, unvested awards and holding lines for William Bindley

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for William Bindley are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
John Ackerman
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for John Ackerman are complete.
Director
n/a−2.21Mn/an/a
Vesting, gifts, unvested awards and holding lines for John Ackerman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Ackerman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Fred Burke
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Fred Burke are complete.
President and Chief Executive Officer, Director
n/a−671Kn/an/a
Vesting, gifts, unvested awards and holding lines for Fred Burke

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Fred Burke are complete; balances and unit counts will be added when the check is finished.

−200Kgifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
75,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

David Morris
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for David Morris are complete.
Executive Vice President, Chief Operating Officer, Director
n/a−188Kn/an/a
Vesting, gifts, unvested awards and holding lines for David Morris

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Morris are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
50,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

Kendall Forbes
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Kendall Forbes are complete.
Officer
n/a−347Kn/an/a
Vesting, gifts, unvested awards and holding lines for Kendall Forbes

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kendall Forbes are complete; balances and unit counts will be added when the check is finished.

−22Kgifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
50,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

Jeffrey Tuch
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jeffrey Tuch are complete.
Senior Vice President, Purchasing & Pricing Analytics
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Jeffrey Tuch

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jeffrey Tuch are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

David Martin
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for David Martin are complete.
Senior Vice President, Technology, Data & Senior Security Officer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for David Martin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Martin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

William Mudd
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for William Mudd are complete.
Senior Vice President, Chief Financial Officer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for William Mudd

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for William Mudd are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

Richard Eakins
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Richard Eakins are complete.
Senior Vice President, Sales
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Richard Eakins

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Richard Eakins are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,000$32.59Mar 13, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

Douglas Towns
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Douglas Towns are complete.
Senior Vice President, General Counsel, Senior Compliance Officer & Corporate Secretary
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Douglas Towns

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Douglas Towns are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

Robert Weir
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Robert Weir are complete.
Senior Vice President, Operations & Regulatory Support
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Robert Weir

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Robert Weir are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

Chris Crisafulli
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Chris Crisafulli are complete.
Senior Vice President, Payor and Industry Strategy
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Chris Crisafulli

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Chris Crisafulli are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,000$34.59Feb 11, 2036$0

Estimate: options held × ($29.68 − strike price), using the most recent insider trade price on Form 4 (Mar 20, 2026), not a market close.

Steven Cosler
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Steven Cosler are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Steven Cosler

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Steven Cosler are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Randall Lewis
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Randall Lewis are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Randall Lewis

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Randall Lewis are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Mary Patchett
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Mary Patchett are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Mary Patchett

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mary Patchett are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for Guardian Pharmacy Services, Inc. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$419M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $419M across 14,124,718 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $419M

Sales with no 10b5-1 plan and no tax reference in the filing. $212M of it is Thomas Salentine Jr.. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Thomas Salentine Jr., Mar 20, 2026

Purchases · 1 buyer (1 trade)

1 officer or director bought shares in this period, in 1 trade(Form 4 code P, leaving out rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust). Across all their filings on record there are 2 purchase trades.

Charitable gifts · 222K shares

Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.

SellerShares soldProceedsUnder a disclosed planShare of totalSales dates
Thomas Salentine Jr.
Director
7.14M$212M0%51%Mar 20, 2026 to Mar 20, 2026
William Bindley
Director
3.57M$106M0%25%Mar 20, 2026 to Mar 20, 2026
John Ackerman
Director
2.21M$65.5M0%16%Mar 20, 2026 to Mar 20, 2026
Fred Burke
President and Chief Executive Officer, Director
671K$19.9M0%5%Mar 20, 2026 to Mar 20, 2026
Kendall Forbes
Officer
347K$10.3M0%2%Mar 20, 2026 to Mar 20, 2026
David Morris
Executive Vice President, Chief Operating Officer, Director
188K$5.6M0%1%Mar 20, 2026 to Mar 20, 2026

Sales by month

MonthSale proceedsDisclosed planTo cover taxesNo plan disclosed
Oct 2025$0$0$0$0
Nov 2025$0$0$0$0
Dec 2025$0$0$0$0
Jan 2026$0$0$0$0
Feb 2026$0$0$0$0
Mar 2026$419M$0$0$419M
Apr 2026$0$0$0$0
May 2026$0$0$0$0
Jun 2026$0$0$0$0
Jul 2026$0$0$0$0
Aug 2026$0$0$0$0
Sep 2026$0$0$0$0
Oct 2026$0$0$0$0
Known gaps and uncertainty16 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Guardian Pharmacy Services, Inc. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology101 filings on record, 52 filed in the 12-month period, and how we read them

All 101 Forms 3, 4 and 5 on record for Guardian Pharmacy Services, Inc. (SEC CIK 1802255), filed from Sep 25, 2024 to Sep 28, 2026; 52 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 13, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.